SCHEMBL13694252

SCHEMBL13694252

C[C@]12CCC(=O)C=C1CCC1C2[C@@H](O)C[C@@]2(C)C1CC[C@]2(O)C(=O)COC(=O)CN1CCN(CCOC(=O)c2ccc(CON(O)O)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ PGR P06401 3/20 0.58
▸ SERPINA6 P08185 2/20 0.58
▸ LMNA P02545 2/20 0.58
▸ AR P10275 2/20 0.58
▸ CHRM1 P11229 2/20 0.58
▸ CYP3A4 P08684 2/20 0.57
▸ NFKB1 P19838 2/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ MAPT P10636 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ NR3C1 P04150 8/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ NR3C2 P08235 2/20 0.52
▸ SHBG P04278 1/20 0.52
▸ KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13692158 0.93 HIF1A (0.62) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13694193 0.90 HIF1A (0.71) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13694233 0.89 HIF1A (0.58) HIF1APGRSERPINA6LMNAAR
SCHEMBL13694229 0.89 HIF1A (0.67) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13692170 0.83 HIF1A (0.76) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13673705 0.81 HIF1A (0.80) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL13692224 0.81 PGR (0.63) HIF1APGRSERPINA6LMNAAR
SCHEMBL4097766 0.81 HIF1A (0.75) HIF1ASMN1; SMN2PGRSERPINA6LMNA
SCHEMBL4091523 0.80 PGR (0.61) HIF1APGRSERPINA6LMNAAR
SCHEMBL4091992 0.80 HIF1A (0.58) HIF1APGRSERPINA6LMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221543-A1 NEW CORTICOSTEROIDS NICOX S A. (FR) 2009-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221543-A1 NEW CORTICOSTEROIDS CYP11B1, NR3C1, NR3C2 HIF1A 1741/4885SMN1; SMN2 4258/4885PGR 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback